OXYMETAZOLINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H24N2O
Molecular Weight	260.3746
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of OXYMETAZOLINE

Structure Search

SMILES

CC1=CC(=C(O)C(C)=C1CC2=NCCN2)C(C)(C)C

InChI

InChIKey=WYWIFABBXFUGLM-UHFFFAOYSA-N

InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18)

HIDE SMILES / InChI

Molecular Formula	C16H24N2O
Molecular Weight	260.3746
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 16:48:33 UTC 2023` Edited by `admin` on `Sat Dec 16 16:48:33 UTC 2023`
Record UNII	8VLN5B44ZY
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OXYMETAZOLINE

Official Name

English

NASACON

Brand Name

English

AFRIN

Brand Name

English

OPERIL

Brand Name

English

OXYMETAZOLINE [VANDF]

Common Name

English

Oxymetazoline [WHO-DD]

Common Name

English

oxymetazoline [INN]

Common Name

English

PHENOL, 3-((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)METHYL)-6-(1,1-DIMETHYLETHYL)-2,4-DIMETHYL-

Systematic Name

English

OXYMETAZOLINE [HSDB]

Common Name

English

6-TERT-BUTYL-3-(2-IMIDAZOLIN-2-YLMETHYL)-2,4-DIMETHYLPHENOL

Systematic Name

English

OXYMETAZOLINE [MI]

Common Name

English

Classification Tree Code System Code

WHO-VATC

QR01AA05

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

WHO-ATC

S01GA04

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

WHO-ATC

R01AB07

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

NDF-RT

N0000192562

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

WHO-VATC

QR01AB07

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

NCI_THESAURUS

C29709

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

WHO-ATC

R01AA05

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

WHO-VATC

QS01GA04

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

Code System Code Type Description

ECHA (EC/EINECS)

216-079-1

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

DRUG CENTRAL

2032

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

ChEMBL

CHEMBL762

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

NCI_THESAURUS

C61871

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

HSDB

3143

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

MERCK INDEX

m8335

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

Merck Index

MESH

D010109

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

CHEBI

7862

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

RXCUI

7812

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

RxNorm

DRUG BANK

DB00935

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

SMS_ID

100000083285

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

EPA CompTox

DTXSID3040691

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

EVMPD

SUB09567MIG

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

IUPHAR

124

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

DAILYMED

8VLN5B44ZY

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

NDF-RT

N0000011304

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

Imidazolines [Chemical/Ingredient]

PUBCHEM

4636

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

LACTMED

Oxymetazoline

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

FDA UNII

8VLN5B44ZY

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

NDF-RT

N0000009908

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

Vasoconstriction [PE]

INN

1400

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

CAS

1491-59-4

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

WIKIPEDIA

OXYMETAZOLINE

Created by admin on Sat Dec 16 16:48:34 UTC 2023 , Edited by admin on Sat Dec 16 16:48:34 UTC 2023

PRIMARY

Related Record Type Details


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> NON-SUBSTRATE

Amount:


					93V99BB37L

ALPHA-2B ADRENERGIC RECEPTOR

TARGET -> AGONIST

Comments:

Binding Assay

Qualification:

IC50

Amount:


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> NON-SUBSTRATE

Amount:


					K89MJ0S5VY

OXYMETAZOLINE HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> NON-SUBSTRATE

Amount:


					L0423Z5LDW

CYTOCHROME P450 2C8

METABOLIC ENZYME -> NON-SUBSTRATE

Amount:


					50U1BO5G5P

ALPHA-2A ADRENERGIC RECEPTOR

TARGET -> AGONIST

Interaction Type:

SHORT-ACTING


					VK4SQL11C0

CYTOCHROME P450 1A2

METABOLIC ENZYME -> NON-SUBSTRATE

Amount:


					081I12ZA58

CYTOCHROME P450 2C19

METABOLIC ENZYME -> SUBSTRATE

Amount:


					0UY97CSG1T

CYTOCHROME P450 2B6

METABOLIC ENZYME -> NON-SUBSTRATE

Amount:


					P5O3A2DHB2

ALPHA-1D ADRENERGIC RECEPTOR

TARGET -> AGONIST

Comments:

Binding Assay

Qualification:

IC50

Amount:


					3T7136LE8K

ALPHA-1A ADRENERGIC RECEPTOR

TARGET -> AGONIST


					03BYF220B6

CYTOCHROME P450 2E1

METABOLIC ENZYME -> NON-SUBSTRATE

Amount:


					Q7A4S7HOP4

ALPHA-1B ADRENERGIC RECEPTOR

TARGET -> AGONIST

Qualification:

IC50

Amount:

Related Record Type Details


					DOC4783X95

2-HYDROXY-4-(1H-IMIDAZOL-2-YLMETHYL)-.BETA.,.BETA.,3,5-TETRAMETHYL-BENZENEETHANOL

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					J9DT0BT6DL

6-(1,1-DIMETHYLETHYL)-3-(1H-IMIDAZOL-2-YLMETHYL)-2,4-DIMETHYLPHENOL

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					RZN45T7DVU

Oxymetazoline glutathione metabolic conjugate

METABOLITE REACTIVE TYPE->PARENT

Amount:


					ND453C04TL

4-((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)METHYL)-2-HYDROXY-.BETA.,.BETA.,3,5-TETRAMETHYL-BENZENEETHANOL

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:

Related Record Type Details


					8VLN5B44ZY

ACTIVE MOIETY

Amount: